Individually tailored treatment in type 2 diabetes

Phase 1

Active, not recruiting

• Conditions: Type 2 diabetes; MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861; Therapeutic area: Diseases [C] - Hormonal diseases [C19]

• Registration Number: EUCTR2012-004883-23-DK
• Lead Sponsor: Henning Beck-Nielsen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-12-20
• Last Update Posted: 2016-10-17

Recruitment & Eligibility

• Status: Not Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1)Newly discovered T2D patients of both sex`
2)Participation in the DD2 cohort
3)Signed informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1696
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 550

Exclusion Criteria

1)Patients with age under 18
2)Type 1 diabetes
3)Life expectancy below 2 years
4)Psychiatric or mental disease
5)Ongoing abuse of alcohol or illicit drugs
6)Participation in any other clinical trial
7)Pregnancy at time of inclusion or planned future pregnancy (A negative pregnancy test is mandatory before inclusion. In women who are sterile, infertile or is postmenopausal (12 month without menstruation) this test is omitted.)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified